Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CAPECITABINE | 150MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223358 |
| CAPECITABINE | 500MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223361 |
| QUETIAPINE FUMARATE XR | 300MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223365 |
| OLMESARTAN/HCTZ | 40MG 25MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223370 |
| QUETIAPINE FUMARATE XR | 400MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223373 |
| LETROZOLE | 2.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223376 |
| QUETIAPINE FUMARATE XR | 200MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223380 |
| OLMESARTAN/HCTZ | 40MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223383 |
| OLMESARTAN/HCTZ | 20MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223386 |
| ALENDRONATE | 70MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223392 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-27 | 223453 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-26 | 223456 |
| ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-27 | 2024-05-17 | 223485 |
| MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2024-04-01 | 2024-04-01 | 224066 |
| CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-04-09 | 2024-04-10 | 224727 |
| AZITHROMYCIN | 250MG | TABLET | Resolved | 2024-04-10 | 2024-05-02 | 224788 |
| CARVEDILOL | 12.5MG | TABLET | Resolved | 2024-04-10 | 2024-04-23 | 224791 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Actual shortage | 2024-04-10 | 2024-04-11 | 224794 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-04-10 | 2024-04-11 | 224797 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-04-10 | 2024-05-22 | 224800 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |